Brief: Antengene Corp Says Taiwan Food And Drug Administration Approved New Drug Application
21/10/2022 13:39
Oct 21 (Reuters) - Antengene Corporation Ltd 6996.HK :
* TAIWAN FOOD AND DRUG ADMINISTRATION HAS APPROVED A NEW
DRUG
APPLICATION OF XPO1 INHIBITOR ATG-010
Further company coverage: 6996.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106